The individual members of a national paediatric organisation which is a full member of EAP, are by default, without any subscription fee, non-voting individual members of EAP and they can participate in the activities of the Permanent councils and strategic advisory groups.
Affiliated Individual Membership is open to citizens of all countries.
These members shall have a university degree; they may be board-certified paediatricians/specialists in paediatrics (or equivalent) or any other physician or scientist with a special interest in paediatrics. Active affiliated individual members may assign themselves to one of the Permanent Councils but they do not have any voting rights in the General Assembly. They can participate in the strategic advisory groups of EAP.
Membership benefits
As A Member You Will Enjoy The Following Benefits:
Reduced Registration Fees to EAP, EAPS congresses and EAP Educational Meetings
Opportunity to be Awarded a Grant of EAP Membership & Registration
Accreditation Courses on Various Topics
EAP Newsletter, Periodic Updates
Congress Session Webcasts, e –Posters
Take part in the different working groups
An Opportunity to Make a Difference!
Your Enquiries Are Welcome
We will respond to you by Email
Core-MD Project
Coordinating Research and Evidence for Medical Devices (CORE-MD)
New ways to test high-risk medical devices.
Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.
It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.